Results for tag: "Alglucerase"

Alglucerase is a drug used to treat Gaucher disease, a rare genetic disorder that affects the body's ability to break down certain fats. It is a form of enzyme replacement therapy, which replaces the missing enzyme in the body with a synthetic version. Alglucerase is used to reduce the symptoms of Gaucher disease, such as anemia, bone pain, and enlargement of the liver and spleen. It is also used to reduce the risk of complications from the disease, such as bone fractures and organ damage. The Alglucerase market is a subset of the larger Gastrointestinal Drugs market. It is a niche market, as Gaucher disease is a rare disorder. Alglucerase is the only approved drug for the treatment of Gaucher disease, and is the only drug available in the market. Some companies in the Alglucerase market include Genzyme Corporation, Shire Pharmaceuticals, and Sanofi-Aventis. Show Less Read more